Vaccine design for severe acute respiratory syndrome coronavirus

Viral Immunology
Yuxian He, Shibo Jiang

Abstract

Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a new coronavirus (SARS-CoV). Recent studies suggest that SARS-CoV is zoonotic and may have a broad host range besides humans. Although the global outbreak of SARS has been contained, there are serious concerns over its re-emergence and bioterrorism potential. As a part of preparedness, development of a safe and effective vaccine is one of the highest priorities in fighting SARS. A number of candidate vaccines, using a variety of approaches, are under development. The first vaccine tested in clinical trial is made from the inactivated form of SARS-CoV. Several live attenuated, genetically engineered or vector vaccines encoding the SARS-CoV spike (S) protein have been in pre-clinical studies. These vaccine candidates are effective in terms of eliciting protective immunity in the vaccinated animals. However, caution should be taken with the safety of whole virus or full-length S protein-based immunogens in humans because they may induce harmful immune or inflammatory responses. We propose to use the receptor-binding domain (RBD) of SARS-CoV S protein (residues 318--510) for developing a safe and effective subunit SARS vaccine, as it is not only a...Continue Reading

References

Nov 1, 1993·Veterinary Microbiology·L J Saif
Apr 1, 1997·Virus Research·R Buckland, T F Wild
Apr 12, 2003·The New England Journal of Medicine·Christian DrostenHans Wilhelm Doerr
Apr 12, 2003·The New England Journal of Medicine·Thomas G KsiazekUNKNOWN SARS Working Group
Apr 25, 2003·Lancet·J S M PeirisUNKNOWN SARS study group
May 6, 2003·Science·Marco A MarraRachel L Roper
May 16, 2003·Nature·Ron A M FouchierAlbert D M E Osterhaus
May 30, 2003·Nature·David Cyranoski, Alison Abbott
May 30, 2003·Nature·Hannah Hoag
Sep 27, 2003·Biochemical and Biophysical Research Communications·Ottavia SpigaNeri Niccolai
Oct 31, 2003·Nature·Byron E E MartinaAlbert D M E Osterhaus
Dec 4, 2003·Biochemical and Biophysical Research Communications·Xiaodong XiaoDimiter S Dimitrov
Dec 13, 2003·The Journal of Biological Chemistry·Swee Kee WongMichael Farzan
Dec 13, 2003·Journal of Virology·John Stavrinides, David S Guttman
Dec 17, 2003·Cell·Dimiter S Dimitrov
Jan 13, 2004·Biochemical and Biophysical Research Communications·Ponraj PrabakaranDimiter S Dimitrov
Feb 10, 2004·Biochemical and Biophysical Research Communications·Peigang WangHongkui Deng
Feb 14, 2004·Science·Eliot Marshall, Martin Enserink
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jianhua SuiWayne A Marasco
Mar 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Graham SimmonsPaul Bates
Apr 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Himani BishtBernard Moss
May 27, 2004·Physiological Genomics·Denong Wang, Jiahai Lu
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ursula J BuchholzPeter L Collins
Jul 24, 2004·Expert Review of Vaccines
Aug 18, 2004·International Immunology·Naomi TakasukaYasuko Tsunetsugu-Yokota
Aug 21, 2004·The Journal of Infectious Diseases·Yuchun NieMingxiao Ding
Sep 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuxian HeShibo Jiang
Sep 25, 2004·Immunology Letters·Sheng XiongJiang-lin Fan
Oct 27, 2004·Emerging Infectious Diseases·Guodong LiangUNKNOWN SARS Diagnosis Working Group
Nov 9, 2004·Biochemical and Biophysical Research Communications·Yuxian HeShibo Jiang

❮ Previous
Next ❯

Citations

May 16, 2006·Journal of Structural Biology·Brian TripetRobert S Hodges
Apr 2, 2008·Expert Review of Vaccines·Oyindasola Oyelaran, Jeffrey C Gildersleeve
Mar 3, 2018·Viruses·Aasiyah Chafekar, Burtram C Fielding
May 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuxian HeShibo Jiang
Jul 14, 2020·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·V V OberemokA V Kubyshkin
May 20, 2020·Journal of Zhejiang University. Science. B·Yu ShiZhi Chen
Jul 28, 2020·Vaccines·Daniel E Speiser, Martin F Bachmann
Apr 30, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Swayam PrakashLbachir BenMohamed
Nov 28, 2021·Biotechnology Letters·Farshad HemmatiAlireza Afsharifar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.